Physician profile
Edward Allen
NPI 1649510116
$2,061.23
in general payments reported to CMS, 2019-2025
19 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $555 · 2021: $280 · 2022: $66.47 · 2023: $97.87 · 2024: $125 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $528.99 | 2019-2022 | |
| Lilly USA, LLC | $375.90 | 2019-2023 | Mounjaro |
| Novo Nordisk INC | $215.45 | 2020-2025 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $214.24 | 2019-2020 | |
| Pfizer INC. | $128.83 | 2021-2023 | |
| Exact Sciences Corporation | $122.73 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Abbvie INC. | $96.61 | 2020 | |
| Amarin Pharma, INC. | $64.32 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $56.82 | 2020-2021 | |
| Smith+Nephew, INC. | $39.47 | 2025 | Collagenase Santyl |
| Glaxosmithkline, LLC. | $38.18 | 2024-2025 | Shingrix, Arexvy |
| Inari Medical, INC. | $28.66 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.87 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $26.79 | 2025 | |
| Qiagen, LLC | $21.06 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.90 | 2020 | |
| Althera Pharmaceuticals LLC | $20.36 | 2021 | |
| Genentech USA, INC. | $19.74 | 2019 | |
| Janssen Biotech, INC. | $14.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.